Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TLC

Taiwan Liposome (TLC) Stock Price, News & Analysis

Taiwan Liposome logo

About Taiwan Liposome Stock (NASDAQ:TLC)

Advanced Chart

Key Stats

Today's Range
$7.00
$7.09
50-Day Range
$6.76
$7.63
52-Week Range
$4.07
$7.70
Volume
12,421 shs
Average Volume
133,095 shs
Market Capitalization
$294.54 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TLC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Taiwan Liposome and its competitors with MarketBeat's FREE daily newsletter.

TLC Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Headlines

TLC Stock Analysis - Frequently Asked Questions

Taiwan Liposome Company, Ltd. (NASDAQ:TLC) announced its earnings results on Wednesday, October, 28th. The company reported ($0.19) EPS for the quarter, missing analysts' consensus estimates of ($0.13) by $0.06. The company earned $2.28 million during the quarter, compared to analysts' expectations of $0.38 million. Taiwan Liposome had a negative trailing twelve-month return on equity of 120.45% and a negative net margin of 299.27%.

Taiwan Liposome (TLC) raised $29 million in an initial public offering on the week of November 19th 2018. The company issued 5,000,000 shares at a price of $5.80 per share. Cantor served as the underwriter for the IPO and CLSA, H.C. Wainwright, Janney Montgomery Scott and Laidlaw & Company (UK) Ltd. were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Taiwan Liposome investors own include Avino Silver & Gold Mines (ASM), Trevena (TRVN), Bionano Genomics (BNGO), Pfizer (PFE), Wells Fargo & Company (WFC), Aadi Bioscience (AADI) and BioLineRx (BLRX).

Company Calendar

Last Earnings
10/28/2020
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:TLC
CIK
1722890
Fax
N/A
Employees
2,020
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$35.02 million
Net Margins
-299.27%
Pretax Margin
-306.10%
Return on Equity
-120.45%
Return on Assets
-55.11%

Debt

Debt-to-Equity Ratio
0.67
Current Ratio
3.01
Quick Ratio
3.01

Sales & Book Value

Annual Sales
$3.63 million
Price / Sales
81.14
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.83 per share
Price / Book
8.43

Miscellaneous

Outstanding Shares
42,077,000
Free Float
N/A
Market Cap
$294.54 million
Optionable
Not Optionable
Beta
0.99
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:TLC) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners